 Photodynamic therapy chloroaluminum-sulfonated phthalocyanine vascular effects new photosensitizing agent independent influence tumor growth cutaneous wound model Six-week-old Harlan-Sprague-Dawley Fuzzy rats standard fashion animals groups first group chloroaluminum-sulfonated phthalocyanine second group light third group chloroaluminum-sulfonated phthalocyanine light Photodynamic therapy chloroaluminum-sulfonated phthalocyanine direct effect neovasculature healing wound vasodilatation wound neovasculature hours completion chloroaluminum-sulfonated phthalocyanine-photodynamic therapy therapeutic window therapies clinical efficacy